The peptide Ac2-26 preserves mitochondrial function and neuronal survival in human retinal cells and organoids under hyperglycemic and inflammatory stress.
It is demonstrated that Ac2-26 acts as a pro-resolving neuroprotective agent that targets convergent inflammatory and mitochondrial pathways involved in early diabetic retinal degeneration, highlighting the FPR2-p38-NOX4 axis as a promising therapeutic target for early intervention in diabetic retinopathy.